-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q7jr+blucvdEJRB21l0C8QdJVdXCrYDkL1Jg3sBsY6Dzf+xa3YEFD/NwT6nM0REd WRnLnTTu4fipK0UM+Hqo6w== 0001140361-09-016525.txt : 20090716 0001140361-09-016525.hdr.sgml : 20090716 20090716163202 ACCESSION NUMBER: 0001140361-09-016525 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090715 FILED AS OF DATE: 20090716 DATE AS OF CHANGE: 20090716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gyenes Lawrence A CENTRAL INDEX KEY: 0001301629 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10352 FILM NUMBER: 09948476 MAIL ADDRESS: STREET 1: C/O SAVIENT PHARMACEUTICALS, INC. STREET 2: ONE TOWER CENTER BLVD., 14TH FLOOR CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLUMBIA LABORATORIES INC CENTRAL INDEX KEY: 0000821995 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592758596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 354 EISENHOWER PARKWAY CITY: LIVINGSTON STATE: NJ ZIP: 07039 BUSINESS PHONE: 9739943999 MAIL ADDRESS: STREET 1: 354 EISENHOWER PARKWAY CITY: LIVINGSTON STATE: NJ ZIP: 07039 3/A 1 doc1.xml FORM 3/A X0203 3/A 2009-07-15 2009-07-16 0 0000821995 COLUMBIA LABORATORIES INC CBRX 0001301629 Gyenes Lawrence A 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 0 1 0 0 SVP, CFO Employee stock option 1.17 2010-07-15 2016-07-15 $0.01 per value common stock 125000 D The option becomes exercisable in four equal annual installments, commencing one year from the date of grant. /S/ Lawrence A. Gyenes 2009-07-16 EX-24.1 2 poa1.htm POWER OF ATTORNEY Unassociated Document


Exhibit 24.1







Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn: Filing Desk




Ladies and Gentlemen:

By means of this letter, I authorize Michael McGrane and Robert S. Mills, or either of them individually, to sign on my behalf all forms required under Section 16(a) of the Securities Exchange Act of 1934, as amended, relating to transactions involving the stock or derivative securities of Columbia Laboratories, Inc.  Either such individual is accordingly authorized to sign any Form 3, Form 4, Form 5, or amendment thereto, that I am required to file with the same effect as if I had signed it myself.

This authorization, signed this 15th day of July, 2009, shall remain in effect until revoked in writing by me. This authorization revokes all prior authorizations by me relating to the subject matter hereof.


Yours truly,



/S/ Lawrence A. Gyenes                                           
Lawrence A. Gyenes
Senior Vice President, Chief Financial Officer,
     & Treasurer

 -----END PRIVACY-ENHANCED MESSAGE-----